![]() |
市场调查报告书
商品编码
1822291
全球横向流动化验组件市场(按产品、技术、应用、最终用户和地区划分)- 预测至 2030 年Lateral Flow Assay Components Market by Type (Membrane, Pad), Application (Clinical Testing (Infectious, Cardiac Marker Test, Fertility, Pregnancy, Cholesterol Testing), Veterinary, Food Safety), Technique, End User & Region - Global Forecast to 2030 |
全球横向流动化验(LFA) 组件市场预计将从 2025 年的 3.924 亿美元成长到 2030 年的 4.862 亿美元,预测期内复合年增长率为 4.4%。
调查范围 | |
---|---|
调查年份 | 2024-2030 |
基准年 | 2024 |
预测期 | 2025-2030 |
对价单位 | 金额(十亿美元) |
部分 | 按产品、技术、应用、最终用户和地区 |
目标区域 | 北美、欧洲、亚太地区、拉丁美洲、中东和非洲、海湾合作委员会国家 |
近年来,受感染疾病疫情上升、就地检验需求成长以及家庭诊断普及率不断提高等因素的推动,横向流动化验组件市场取得了显着增长。膜、垫片及相关材料的不断发展提高了检测准确性,缩短了交付时间,使其在临床、兽医、食品安全和药物开发领域的应用范围不断扩大。除了老牌企业外,越来越多的小型专业製造商正在主导材料设计和生产方法的创新,提供独特的解决方案,以满足最终用户的多样化需求。
横向流动化验组件市场分为夹心法、竞争性分析及多重侦测分析。其中,夹心法因其高灵敏度、特异性以及适用于检测细菌病原体、病毒抗原和关键生物标记等大型分析物而在2024年占据了最大的市场份额。此方法将分析物「夹」在两种高度特异性的抗体之间,产生与分析物浓度直接相关的讯号,以获得可靠的定量结果。夹心法在最常见的诊断测试中的应用进一步证明了其优越性,例如妊娠测试(人类绒毛膜促性腺激素 (HCG))、传染病检查(爱滋病毒、乙型肝炎、幽门螺旋桿菌)和心臟标记检测(肌钙蛋白、CK-MB、肌红蛋白)。无论分析物浓度如何,夹心法都能产生持续强劲的对照线讯号,从而提高了测试的可靠性,这对于临床和家庭诊断至关重要。随着医疗保健提供者越来越多地采用即时诊断 (POC) 解决方案,针对夹心检测方案量身定制的膜、结合垫片和奈米颗粒的需求持续增长。相较之下,竞争性检测适用于具有单一抗原决定簇的小分子,并且在药物滥用检测和某些食品安全应用等领域仍然重要。同时,多重检测方法因其能够同时分析多个靶点而日益普及。然而,夹心检测的广泛临床应用和成熟的诊断准确性才是全球市场组件消费的主要驱动力。
按最终用户划分,横向流动化验组件市场可细分为医疗设备製造商和医疗设备契约製造製造商。由于医疗设备製造商在各种诊断设备的设计、工程和製造中发挥重要作用,预计到 2024 年他们将占据市场主导地位并占据主要份额。膜、垫、结合物和外壳材料的主要消费者包括雅培(美国)、霍夫曼罗氏(美国)、丹纳赫集团(美国)、西门子医疗(美国)、 垫片 -Rad Laboratories(美国)、赛默飞世尔科技(美国)、珀金埃尔默(美国)、Hologic(美国)和默克集团(德国)。感染疾病的流行、老年人口的增长以及家庭和照护现场诊断的广泛采用,正在推动 LFA 组件融入诊断产品系列。因此,医疗设备製造商是组件市场的主要需求驱动力。同时,医疗设备契约製造製造商是一个稳定成长的细分市场。随着契约製造製造商 (OEM) 将生产外包以降低成本、快速扩充性并获取专业知识,合约製造商已成为膜、垫片和其他耗材的重要买家。这一趋势在亚太地区尤其明显,该地区有利的人事费用和支持性的製造生态系统正在鼓励跨国公司与本地生产商合作,进一步推动该地区对零件的需求。
全球横向流动化验组件市场分为五个区域:北美、欧洲、亚太、拉丁美洲以及中东和非洲。预计在预测期内,亚太地区将在横向流动化验组件市场中实现最高的复合年增长率,这得益于医疗保健的快速扩张、强劲的经济成长以及国内外参与者不断增加的投资。这一成长的主要驱动力包括中国、印度、日本、韩国、中国台湾、澳洲和新加坡等高成长国家和地区。医疗保健支出增加、人口老化、预期寿命延长以及对即时检测和家庭检测的需求增加等因素,正在推动对膜、结合垫片、金奈米颗粒和其他侧流分析组件的需求。由于医疗保健基础设施的不断扩大、收入的不断增长以及政府对诊断技术的重视,中国和印度仍然是最具影响力的市场。印度在2023-2024财政年度增加的医疗保健预算为这些努力提供了支持。同时,越南、印尼和菲律宾等东南亚国家凭藉着强劲的GDP成长、製造能力的提升以及外国投资,正成为新的成长中心。儘管存在这些成长动力,但诸如对近距离检测益处的认知度低、报销机制不完善以及农村和偏远地区基础设施缺口等挑战,仍然是全面普及的障碍。然而,凭藉Advanced Microdevices Ltd.(印度)、J. Mitra, Inc.(印度)、J. Mitra & Co.(印度)、Nupore Filtration(中国)和Equinox(中国)等具有竞争力的本地製造商,以及跨国供应商的存在,该地区的LFA组件生态系统得以增强,并使其保持了增长最快的区域市场地位。
本报告研究了全球横向流动化验组件市场,按产品、技术、应用、最终用户和地区进行细分,并提供了参与市场的公司概况。
The global lateral flow assay (LFA) components market is projected to reach USD 486.2 million by 2030 from USD 392.4 million in 2025, at a CAGR of 4.4% during the forecast period.
Scope of the Report | |
---|---|
Years Considered for the Study | 2024-2030 |
Base Year | 2024 |
Forecast Period | 2025-2030 |
Units Considered | Value (USD billion) |
Segments | Product, Application, Technique, Sample Type, and End User |
Regions covered | North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries |
In recent years, the lateral flow assay components market has gained significant momentum, driven by the increasing prevalence of infectious diseases, rising demand for point-of-care testing, and greater adoption of home-based diagnostics. Ongoing improvements in membranes, pads, and related materials have improved test accuracy and reduced turnaround times, expanding their use in clinical, veterinary, food safety, and drug development settings. Along with established companies, a growing number of small and specialized manufacturers are leading innovation in material design and production methods, offering unique solutions that meet diverse end-user needs and requirements.
"The sandwich assays segment of the lateral flow assay components market, by technique, is expected to hold the largest position during the forecast period."
The lateral flow assay components market is divided into sandwich assays, competitive assays, and multiplex detection assays. Among these, sandwich assays held the largest market share in 2024, due to their higher sensitivity, specificity, and suitability for detecting larger analytes like bacterial pathogens, viral antigens, and key biomarkers. In this method, the analyte is "sandwiched" between two highly specific antibodies, creating a signal that directly correlates with analyte concentration, ensuring reliable and quantitative results. The dominance of sandwich assays is further supported by their use in some of the most common diagnostic tests, including pregnancy testing (hCG), infectious disease testing (HIV, hepatitis B, H. pylori), and cardiac marker detection (troponin, CK-MB, myoglobin). Their ability to consistently produce strong control line signals, regardless of analyte levels, improves test reliability-a vital aspect for clinical and home-based diagnostics. As healthcare providers increasingly adopt point-of-care solutions, the demand for membranes, conjugate pads, and nanoparticles tailored to sandwich assay formats continues to grow. In contrast, competitive assays-more suitable for small molecules with a single antigenic determinant-remain important in areas like drug-of-abuse testing and certain food safety applications. Meanwhile, multiplex detection assays are gaining popularity for their capacity to analyze multiple targets simultaneously. Nevertheless, it is the extensive clinical applications and established diagnostic accuracy of sandwich assays that primarily drive the consumption of components worldwide market.
"The medical device manufacturing companies accounted for the largest market share in the lateral flow assay components market, by end user."
The lateral flow assay components market, by end user, is divided into medical device manufacturing companies and medical device contract manufacturing companies. Among these, medical device manufacturing companies led the market in 2024, holding the largest share because of their extensive role in designing, engineering, and producing a wide range of diagnostic devices. These companies, including Abbott (US), Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Siemens Healthineers (Germany), Bio-Rad Laboratories (US), Thermo Fisher Scientific (US), PerkinElmer (US), Hologic (US), and Merck KGaA (Germany), are the main consumers of membranes, pads, conjugates, and housing materials. The increasing prevalence of infectious diseases, the growing elderly population, and the rising adoption of home-based and point-of-care diagnostics have driven the integration of LFA components into diagnostic product portfolios. This has made medical device manufacturers the primary demand drivers in the component market. Meanwhile, medical device contract manufacturing companies form a steadily growing segment. As OEMs outsource production for cost savings, faster scalability, and access to specialized expertise, contract manufacturers are becoming important buyers of membranes, pads, and other consumables. This trend is especially strong in Asia-Pacific, where favorable labor costs and supportive manufacturing ecosystems encourage global companies to partner with local producers, further boosting demand for components from this segment.
"The Asia Pacific is the fastest-growing region of the lateral flow assay components market by region."
The global lateral flow assay components market is segmented into five segments, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to achieve the highest CAGR in the lateral flow assay components market during the forecast period, driven by rapid healthcare expansion, strong economic growth, and increasing investments from both domestic and international players. Key contributors to this growth include high-growth countries such as China, India, Japan, South Korea, Taiwan, Australia, and Singapore. Factors like rising healthcare expenditure, an aging population, longer life expectancy, and the increasing demand for point-of-care and home-based testing are boosting demand for membranes, conjugate pads, gold nanoparticles, and other LFA components. China and India remain the most influential markets due to their expanding healthcare infrastructure, rising incomes, and government focus on diagnostics. India's increased health budget for FY 2023-24 underscores this commitment. Meanwhile, Southeast Asian economies like Vietnam, Indonesia, and the Philippines are emerging as new growth centers, driven by strong GDP growth, increased manufacturing capacity, and foreign investment. Despite these growth drivers, challenges such as limited awareness of near-patient testing benefits, inadequate reimbursement structures, and infrastructural gaps in rural and remote areas pose barriers to full adoption. Nevertheless, the presence of competitive local manufacturers such as Advanced Microdevices Ltd. (India), J. Mitra & Co. (India), Nupore Filtration (China), and Equinox (China), alongside multinational suppliers, is strengthening the region's LFA component ecosystem and maintaining its position as the fastest-growing regional market.
Note 1: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the lateral flow assay components market are Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Ahlstrom (Finland), Advanced Microdevices Pvt. Ltd. (India), DCN Diagnostics (US), Fortis Life Sciences, LLC. (US), Cobetter (China), Axiva Sichem Pvt. Ltd. (India), and Nupore Filtration Systems (India).
Research Coverage
This report examines the lateral flow assay components market based on product, application, technique, end user, and region. It also evaluates factors such as drivers, restraints, opportunities, and challenges impacting market growth, and provides details about the competitive landscape of market leaders. Additionally, the report analyzes micro-markets concerning their individual growth trends. It forecasts the revenue of market segments across five major regions and their respective countries regions).
Reasons to Buy the Report
The report will help both established firms and smaller entrants assess the market, which can assist them in gaining a larger market share. Companies purchasing the report can utilize one or a combination of the strategies listed below to strengthen their market position presence.